Equine gastric ulcer syndrome (EGUS) is the most common disease of the equine stomach with high prevalence of both squamous and glandular disease reported in various populations. The aim of this study was to evaluate the effectiveness of a phytotherapic compound (pHhyloGASTRO) in the therapy of EGUS. The study was performed as a randomized double-blinded single-center study. The study population was composed of 19 equids which were submitted to gastroscopy before and after a 6-week treatment with feed additive (10/19) (pHyloGASTRO, (4)Union B.I.O. srl, Italy) or a placebo (9/19). Severity grade was evaluated on a scale from 0 to 4. The variables of interest were gastric lesion score and improvement grade. Changes and comparisons of variables were performed by contingency table analyses. P level of significance was set at .05 in all analyses. In terms of gastric lesion scores, the treated group improved significantly compared to the placebo group. pHyloGASTRO seems to be effective in the treatment of EGUS. Further studies are needed to verify whether prolonged administration of pHyloGASTRO could be more effective in completely healing gastric lesions. (C) 2016 Elsevier Inc. All rights reserved.

Bonelli, F., Busechian, S., Meucci, V., Caporrino, G., Briganti, A., Rueca, F., et al. (2016). pHyloGASTRO in the Treatment of Equine Gastric Ulcer Lesions. JOURNAL OF EQUINE VETERINARY SCIENCE, 46, 69-72 [10.1016/j.jevs.2016.06.069].

pHyloGASTRO in the Treatment of Equine Gastric Ulcer Lesions

Busechian, S;
2016-11-01

Abstract

Equine gastric ulcer syndrome (EGUS) is the most common disease of the equine stomach with high prevalence of both squamous and glandular disease reported in various populations. The aim of this study was to evaluate the effectiveness of a phytotherapic compound (pHhyloGASTRO) in the therapy of EGUS. The study was performed as a randomized double-blinded single-center study. The study population was composed of 19 equids which were submitted to gastroscopy before and after a 6-week treatment with feed additive (10/19) (pHyloGASTRO, (4)Union B.I.O. srl, Italy) or a placebo (9/19). Severity grade was evaluated on a scale from 0 to 4. The variables of interest were gastric lesion score and improvement grade. Changes and comparisons of variables were performed by contingency table analyses. P level of significance was set at .05 in all analyses. In terms of gastric lesion scores, the treated group improved significantly compared to the placebo group. pHyloGASTRO seems to be effective in the treatment of EGUS. Further studies are needed to verify whether prolonged administration of pHyloGASTRO could be more effective in completely healing gastric lesions. (C) 2016 Elsevier Inc. All rights reserved.
nov-2016
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MVET-04/B - Clinica medica veterinaria
English
Equid
EGUS
Treatment
Nutraceutical compound
pHyloGASTRO
Bonelli, F., Busechian, S., Meucci, V., Caporrino, G., Briganti, A., Rueca, F., et al. (2016). pHyloGASTRO in the Treatment of Equine Gastric Ulcer Lesions. JOURNAL OF EQUINE VETERINARY SCIENCE, 46, 69-72 [10.1016/j.jevs.2016.06.069].
Bonelli, F; Busechian, S; Meucci, V; Caporrino, G; Briganti, A; Rueca, F; Zappulla, F; Ferini, E; Ghiandai, L; Sgorbini, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
35. JEVS, 2016.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 220.71 kB
Formato Adobe PDF
220.71 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/403564
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 13
social impact